Jon Sockell, Co-founder and COO of Limbix, sits down with us in this Fireside Chat. See how Limbix is paving the way for prescription digital therapeutics and learn from their trials, tribulations, successes, and vision for the future. Get inspired to ask your next big question or navigate into some new uncharted waters for your company. This is a time of unprecedented change. It is an opportunity to leverage these days of variance and to create differentiation using "functional speed". Jon gets us all motivated to leverage the groundswell of momentum that is swirling around us in this new post-COVID-19 #newnormal world in which we live!
To find out more about Impetus: https://www.meetwithimpetus.com
Impetus Digital Website: https://www.impetusdigital.com/
Impetus Digital Twitter: https://twitter.com/impetus_digital
Impetus YouTube: https://www.youtube.com/ImpetusDigital
Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/
Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/
Jon Sockell: https://www.linkedin.com/in/jsockell/
Limbix: https://www.limbix.com/
Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.
Click the social media buttons to share this episode with your network!
To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.com
Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/
Impetus Digital Website: Home Page
LinkedIn: https://www.linkedin.com/company/impetus-digital/
Twitter: impetus_digital
YouTube: Impetus Digital